Drug Approval | March 19, 2024
Carbogen Amcis (Shanghai) completed ANVISA Audit
A five-day inspection was concluded successfully with no critical and no major observations raised
A five-day inspection was concluded successfully with no critical and no major observations raised
ANVISA issues CGMP to Concord Biotech’s Unit I
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
The companies will work with investigators to share the results with the scientific community
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
Subscribe To Our Newsletter & Stay Updated
